Alector to participate in the goldman sachs 46th annual global healthcare conference

South san francisco, calif., june 03, 2025 (globe newswire) -- alector, inc. (nasdaq: alec), a late-stage clinical biotechnology company focused on developing therapies to counteract the devastating progression of neurodegeneration, today announced that management will participate in a fireside chat at the goldman sachs 46th annual global healthcare conference on tuesday, june 10, 2024, at 8:40 am et.
ALEC Ratings Summary
ALEC Quant Ranking